Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats by Ceprián, María et al.
1Edited by: 
Francisco Ciruela, 
University of Barcelona, 
Spain
Reviewed by: 
Christiane Charriaut-Marlangue, 
Institut National de la Santé 
et de la Recherche Médicale 
(INSERM), France 
Junhua Xiao, 
The University of Melbourne, 
Australia
*Correspondence: 
José Martínez-Orgado 
jose.martinezo@salud.madrid.org
Specialty Section: 
This article was submitted to 
Neuropharmacology, 
a section of the journal 
Frontiers in Pharmacology
Received: 01 April 2019
Accepted: 30 August 2019
Published: 26 September 2019
Citation: 
Ceprián M, Vargas C, 
García-Toscano L, Penna F, 
Jiménez-Sánchez L, Achicallende S, 
Elezgarai I, Grandes P, Hind W, 
Pazos MR and Martínez-Orgado J 
(2019) Cannabidiol Administration 
Prevents Hypoxia-Ischemia-Induced 
Hypomyelination in Newborn Rats. 
Front. Pharmacol. 10:1131. 
doi: 10.3389/fphar.2019.01131
Cannabidiol Administration 
Prevents Hypoxia-Ischemia-Induced 
Hypomyelination in Newborn Rats
María Ceprián 1,2, Carlos Vargas 3, Laura García-Toscano 2,4,5, Federica Penna 6, 
Laura Jiménez-Sánchez 1, Svein Achicallende 7, Izaskun Elezgarai 7, Pedro Grandes 7, 
William Hind 8, M. Ruth Pazos 1,9 and José Martínez-Orgado 1,3*
1 Department of Experimental Medicine, Health Research Institute Puerta de Hierro Majadahonda, Madrid, Spain, 2 Departamento 
de Bioquímica y Biología Molecular, Facultad de Medicina, Instituto Universitario de Investigación en Neuroquímica, Universidad 
Complutense, Madrid, Spain, 3 Division of Neonatology, Hospital Clínico San Carlos - IdISSC, Madrid, Spain, 4 CIBER de 
Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain, 5 Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), 
Madrid, Spain, 6 Department of DBSV, Laboratory of Neuropsychopharmacology, University of Insubria, Varese, Italy, 7 School of 
Medicine and Nursery, Universidad del País Vasco, Bilbao, Spain, 8 GW Research Ltd, Cambridge, United Kingdom, 9 Laboratorio 
de Apoyo a la Investigación, Hospital Universitario Fundación Alcorcón, Madrid, Spain
Neonatal hypoxia-ischemia (HI) is a risk factor for myelination disturbances, a key factor 
for cerebral palsy. Cannabidiol (CBD) protects neurons and glial cells after HI insult in 
newborn animals. We hereby aimed to study CBD’s effects on long-lasting HI-induced 
myelination deficits in newborn rats. Thus, P7 Wistar rats received s.c. vehicle (HV) or 
cannabidiol (HC) after HI brain damage (left carotid artery electrocoagulation plus 10% O2 
for 112 min). Controls were non-HI pups. At P37, neurobehavioral tests were performed 
and immunohistochemistry [quantifying mature oligodendrocyte (mOL) populations and 
myelin basic protein (MBP) density] and electron microscopy (determining axon number, 
size, and myelin thickness) studies were conducted in cortex (CX) and white matter (WM). 
Expression of brain-derived neurotrophic factor (BDNF) and glial-derived neurotrophic 
factor (GDNF) were analyzed by western blot at P14. HI reduced mOL or MBP in CX 
but not in WM. In both CX and WM, axon density and myelin thickness were reduced. 
MBP impairment correlated with functional deficits. CBD administration resulted in normal 
function associated with normal mOL and MBP, as well as normal axon density and myelin 
thickness in all areas. CBD’s effects were not associated with increased BDNF or GDNF 
expression. In conclusion, HI injury in newborn rats resulted in long-lasting myelination 
disturbance, associated with functional impairment. CBD treatment preserved function 
and myelination, likely as a part of a general neuroprotective effect.
Keywords: hypoxia-ischemia, myelin, cannabidiol, newborn, rat
INTRODUCTION
Neonatal hypoxia-ischemia (HI) is a major cause of neonatal encephalopathy (Volpe 2012; Lee 
et al., 2013). Newborn hypoxic-ischemic encephalopathy (NHIE) has an incidence of 2 to 6 per 1000 
live births (Kurinczuk et al., 2010; Lehtonen et al., 2017). About 25% of affected newborns develop 
long-lasting disabilities, such as cerebral palsy, cognitive impairments, or epilepsy with deleterious 
consequences for the child and family well-being (de Vries and Jongmans, 2010; Martinez-Biarge et al., 
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2011; Lee et al., 2013; Adhikari and Rao, 2016). The complex 
pathophysiology of HI brain damage includes the so-called deadly 
triad oxidative stress, excitotoxicity, and severe inflammatory 
response (Fatemi Fatemi et al., 2009; Hagberg et al., 2015), to 
which late oligodendrocyte progenitors (preOL) are particularly 
sensitive because of the combination of high metabolic demand, 
undeveloped antioxidant system, specific subcellular distribution 
of glutamatergic receptors [including N-methyl--aspartate 
(NMDA) and alpha-3-amino-hydroxy-5-methyl-4-isoxazole 
propionic acid (AMPA)] and particular pro-apoptotic effects of 
cytokines, such as TNFα or IFNγ (Back et al., 2002a; Buntinx et 
al., 2004; Fragoso et al., 2004; Follett et al., 2004; Salter and Fern 
2005; Kim et al., 2011; Li et al., 2013; Janowska and Sypecka, 2018).
Thus, preOL degeneration is enhanced in the brain, both 
in animal models and human newborns after HI damage 
(Segovia et al., 2008; Back et al., 2002a), which eventually leads 
to hypomyelination (Janowska and Sypecka, 2018). In the core 
of the lesion, axonopathy has been observed to overlap with 
hypomyelination in microscopic necrosis region (Buser et al., 2012; 
Back et al., 2002a). Furthermore, this damage in white and grey 
matter has been correlated with a poorer pathology outcome, such 
as motor impairment, delay in language, and behavioral problems 
(de Vries and Jongmans, 2010; Martinez-Biarge et al., 2011).
Cannabidiol (CBD) is the main non-euphoric component 
of Cannabis sativa and is well-known as a potent anti-oxidant 
and anti-inflammatory compound (Mechoulam et al., 2002; 
Mukhopadhyay et al., 2011), properties involved, together with 
modulation of excitotoxicity, in the neuroprotective effects 
demonstrated for CBD in different animal models of NHIE 
(Alvarez et al., 2008; Lafuente et al., 2011; Pazos et al., 2012; 
Pazos et al., 2013; Lafuente et al., 2016). CBD treatment has 
myelin protective effects in different demyelinating disease 
models. CBD prevents oligodendrocyte progenitor (OPC) death 
by both inflammatory and oxidative stress in vitro (Mecha et al., 
2012). In animal models of multiple sclerosis, CBD by itself 
or co-administrated with other cannabinoids improves the 
neurobehavioral outcome, diminishing demyelination severity 
and axonal damage by reducing microglia activation and 
proinflammatory cytokines release (Feliú et al., 2015; Giacoppo 
et al., 2015; Rahimi et al., 2015). However, no assessment of 
CBD’s effects on myelination and oligodendrocyte protection 
was reported in those studies.
The aim of the present work is to determine if CBD may 
prevent HI-induced hypomyelination in immature brain. Mature 
oligodendrocyte population and myelin density are characterized 
in white and grey matter where specific areas have been analyzed. 
Axonopathy and myelin abnormalities are studied by electron 
microscopy to characterize long-term consequences of impaired 
oligodendrocyte maturation.
MATERIALS AND METHODS
HI Brain Damage Induction
All the animal experimental procedures were approved by 
the Ethical Committee for Animal Welfare of the Hospital 
Universitario Puerta de Hierro Majadahonda, and met the 
European and Spanish regulation (2010/63/EU and RD 
1201/2005). HI brain damage protocol was based on that 
previously reported (Pazos et al., 2012). In brief, 7- to 10-day-
old Wistar rats (P7–P10) were anesthetized with sevoflurane 
(5% induction, 1% maintenance) and the left common carotid 
artery was exposed and electrocoagulated. After a 3-h recovery 
period, pups were placed into 500ml jars in a 37°C water bath 
and exposed to hypoxia (10% O2) for 112 min. Similar surgical 
procedures were performed for control animals (SHM, n = 
16), but without carotid electrocoagulation and the following 
hypoxia. Ten minutes after the end of hypoxia, HI pups were 
randomly treated with s.c. injection of pure CBD (HC, n = 29) or 
vehicle (HV, n = 27). CBD (GW Research Ltd, Cambridge, UK) 
was obtained from a 5-mg/ml formulation of CBD in ethanol/
solutol/saline (2:1:17) and further diluted in saline to inject 1 mg/
kg in 0.1 ml final volume Then, rats were returned to the dam and 
weaned at P21 days.
Neurobehavioral Studies (NB)
Thirty days after the Hi insult, two different functional tests 
were performed, following the protocol previously described 
(Pazos et al., 2012). Briefly, lateral bias of sensorimotor deficits 
was assessed using the cylinder rearing test (CRT). Each rat was 
placed in a methacrylate transparent cylinder 20 cm in diameter 
and 30 cm in height. The relative proportion of left (ipsilateral) 
forepaw contacts was calculated as: [(left − right)/(left + right + 
both)] × 100.
Then, non-spatial working memory was assessed using the 
novel object recognition (NOR) test. The rat was allowed to 
explore a box that contained two identical objects and then 
returned to the box where one of the original objects was replaced 
by a new one. The time spent for the exploration of the familiar 
(Tf) and the novel object (Tn) was recorded separately, and a 
discrimination index, [(Tn − Tf)/(Tn + Tf)] × 100, was calculated.
Immunohistochemical Analyses
After the NB studies were completed, rats were sacrificed under 
deep anesthesia (i.p. injection of diazepam/ketamine) and 
transcardially perfused with saline and 4% paraformaldehyde. 
Brains were harvested and embedded in paraffin to obtain 
coronal sections (4 µm thick) corresponding to plate 17 of 
the Paxinos and Watson Atlas (Paxinos and Watson, 1996). 
Mature oligodendrocyte (mOL) populations were studied in 
the ipsilateral cortex (CX) (parieto-occipital cortex) and white 
matter (WM) (external capsula of the corpus callosum) using 
the immunohistochemistry protocol described elsewhere (Pazos 
et al., 2012). Briefly, tissue sections were deparaffinized and, 
after an antigen retrieval procedure, were incubated overnight 
at room temperature with GST-p (1:100; Abcam, UK) or MBP 
antibodies (1:800; Abcam, UK). After extensive washes, tissues 
were incubated with the corresponding Alexa-Fluor conjugated 
secondary antibody (1:200; Life Technologies, Spain) for 2 h at 
37°C. Finally, TO-PRO (1:500; Life Technologies, Spain) was 
used for nucleus staining. A Leica TCS SP5 confocal microscope 
system (Leica, Wetzlar, Germany) was used for slide observation 
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and photography. Three microphotographs were obtained 
for each area of interest for at least eight animals per group. 
Cell density analyses were performed by at least two blinded 
examiners using the ImageJ 1.43u software (NIH, Bethesda, 
USA). MBP signal intensity was determined with the LEICA 
LASF Software (Leica Microsystems, Germany) and expressed as 
ratio of ipsilateral MBP intensity compared to total intensity(Liu 
et al., 2002).
Electron Microscopy Studies
Electron microscopy (EM) studies were performed at P30 as 
described elsewhere (Ford et al., 2015). In brief, rats were deeply 
anesthetized and transcardially perfused with phosphate-buffered 
saline followed by the fixative solution (4% formaldehyde, 
0.2% picric acid, and 0.1% glutaraldehyde in 0.1 M phosphate 
buffer, pH 7.4). Afterward, brains were removed from the skull 
and postfixed in the fixative solution for approximately 1 week 
at 4°C. Brain coronal sections were cut in a vibratome (50 μm 
thick) and immersed in a 1% osmium tetroxide solution for 
1  h at 4°C. Then, sections were dehydrated in graded alcohol 
series to propylene oxide and plastic-embedded in Epon resin 
812. Ultrathin sections of 60 nm were collected on mesh nickel 
grids, stained with 2.5% lead citrate for 20 min, and examined 
in a Philips EM208S electron microscope. Tissue preparations 
for three animals per treatment were photographed by using a 
digital camera coupled to the electron microscope. Two main 
areas were analyzed, external capsule and cerebral cortex, and all 
the ultramicrographs were analyzed using ImageJ software (NIH; 
RRID: SCR_003070).
To calculate the number of axons, 10 EM images per animal 
were taken at 5,600× magnification. The number of cross-
sectional views of myelinated axons were counted per area 
(308  μm2) to normalize the values. All the EM micrographs 
used to analyze myelin sheath thickness and axon perimeter 
were taken at 11,000× magnification. Myelin sheath thickness 
was analyzed in 10 axons per animal, and it was measured in 
four different points of the same axon. To estimate g-ratios, the 
measured inner perimeter (axon) was divided by the measured 
outer perimeter (myelin). 150 axons per treatment were analyzed 
in the external capsule, whereas in the cortex an average of 100 
axons were analyzed.
Western Blot
Brain-derived neurotrophic factor (BDNF) and glial cell-derived 
neurotrophic factor (GDNF) expression was studied one week 
after the HI insult (Ikeda et al., 2002; Jantzie and Todd 2010). 
Rats were sacrificed by carbon dioxide followed by a rapid 
decapitation. Brains were immediately harvested, snap frozen 
in isopentane, and stored at -80°C to carry out biochemical 
studies using the protocol described elsewhere (Pazos et al., 
2012; Pazos et al., 2013). 20 µg of protein from each frozen tissue 
sample was denatured and separated by sodium dodecyl-sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Proteins were 
transferred onto a PVDF membrane (GE Healthcare; UK), and 
remaining binding sites were blocked by one h incubation in 
TBS-Tween (TBST) containing 4% nonfat dried milk at room 
temperature. Subsequently, blots were incubated with α-BDNF 
(1:300; Santa Cruz, USA) or α-GDNF (1:100; Santa Cruz, USA). 
Membranes were finally incubated with the corresponding HRP-
labeled secondary antibodies (1:5000; GE Healthcare, UK) for 
2 h at room temperature. Finally, the peroxidase reaction was 
developed with an Enhance Chemiluminescence (ECL) Kit (GE 
Healthcare; Buckinghamshire, UK) and Gel-Doc station with 
Quantity One 4.5.1 (basic) analysis software (Bio-Rad; Hercules, 
USA) was used for detection. Stain-free technology was used 
to  normalize sample loading (BioRad, Spain) and obtained 
images of both target protein and loaded protein were analyzed 
with ImageLab software (version 6.0.0, Bio-Rad; Hercules, 
USA) to determine the intensity per mm2 of each band and 
lane, respectively.
Statistical Analyses
Statistical analysis was done using the StatPlus:mac Pro v6.1.25 
software (AnalystSoft Inc., Walnut, CA). Normality of data was 
tested using the Kolmogorov-Smirnov test. Since no evidence 
against normality was detected, comparisons between groups 
were made using one-way ANOVA with Bonferroni post hoc 
analysis for multiple comparisons whereas Spearman test was 
used to analyze the correlation between myelin intensity and 
neurobehavioral studies. Results are expressed as mean ± SEM. 
p < 0.05 was considered statistically significant.
RESULTS
Experimental mortality accounted for 15.24% of animals: 5.71% 
died during the surgical procedure, 4.76% during hypoxia, and 
4.76% over the following 7 days.
WM Findings
Density of GSTπ-positive cells (Figure 1A) and MBP intensity 
signal (Figure 1B) were similar in HV or HC and SHM. 
However, EM studies (Figure 2F) revealed that despite the 
normal MBP intensity signal, there was in WM a decrease in 
the number of axons in HV as compared to SHM 1 month after 
HI (Figure  2A). In addition, HV axons presented a thinner 
myelin sheath than those from SHM (Figure 2B). Since axon 
perimeter was also smaller in HV than in SHM animals 
(Figure 2C), myelin sheath thickness was normalized using the 
g-ratio. G-ratio was greater in HV than in SHM, confirming 
that myelin sheath was actually thinner in HV than in SHM 
animals (Figure 2D). EM studies revealed a beneficial effect of 
CBD, so that the number of myelinated axons as well as myelin 
thickness in absolute values or as g-ratio, were similar in HC 
and SHM animals (Figures 2A−D). In HV animals, smaller 
axons showed a trend to present higher g-ratio values (Figure 
2E) whereas in HC animals the relationship between axon size 
and g-ratio values was similar to SHM (Figure 2E). Axon size 
correlated with g-ratio value in all groups (R = 0.32, t = 4.0; 
R = 0.59, t = 8.9; and R = 0.48, t = 7.1, for SHM, HV, and HC, 
respectively, all p < 0.05)
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FIGURE 1 | Quantification of mature oligodendrocyte population and myelin staining in white matter. Representative microphotographs and graphical representation 
of immunohistochemical studies performed in the external capsula of the corpus callosum 30 days after a hypoxic-ischemic (HI) insult induced in P7–10 Wistar 
rats then receiving vehicle (HV) or cannabidiol (HC), or a similar period in control rats (SHM). (A) GST-π (mature oligodendrocyte) and (B) myelin basic protein (MBP) 
staining. Bars represent mean ± SEM. Scale bar: 50 μm.
FIGURE 2 | Myelin study in white matter by electron microscopy. Electron microscopy studies performed in the external capsula of the corpus callosum 30 days 
after a hypoxic-ischemic (HI) insult induced in P7–10 Wistar rats then receiving vehicle (HV) or cannabidiol (HC), or a similar period in control rats (SHM). (A) Number 
of axons (B) myelin sheath thickness (C) Axon perimeter (D) g-ratio (E) Dots and trend lines representing the relationship between axon size and g-ratio values 
(F) Representative micrographs. Bars represent mean ± SEM. Scale bar: 10 µm. *p < 0.05 vs SHM; #p < 0.05 vs HV, by ANOVA.
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Cortex Findings
In this area, the density of GSTπ-positive cells was lower in HV 
than in SHM (Figure 3A), which is in contrast to that observed 
in WM. In addition, MBP intensity signal was reduced in HV 
as compared to SHM (Figure 3B). CBD treatment prevented 
the HI-induced decrease in GSTπ-positive cell number so that 
the number of GSTπ-positive cell was similar in HC and SHM 
(Figure 3A). Similarly, CBD treatment prevented the HI-induced 
decrease of myelin signal so that MBP intensity signal was similar 
in HC and SHM (Figure 3B).
As in WM, EM studies (Figure 4F) in the CX showed a 
decrease in the number of axons in HV as compared to SHM 
(Figure 4A). Myelinated axons in CX showed a thinner myelin 
sheath in absolute terms (Figure 4B) and after normalization 
to g-ratio (Figure 4D). CBD administration after the HI insult 
prevented these changes from occurring in the CX, with 
myelinated axon number as well as myelin thickness in absolute 
values or as G-ratio similar in HC and SHM animals (Figures 
4A−D). Relationship between axon size and g-ratio values was 
similar in all groups (Figure 4E). Axon size correlated with 
g-ratio value in all groups (R = 0.32, t = 3.5; R = 0.54, t = 5.6; and 
R = 0.58, t = 7.2, for SHM, HV, and HC, respectively, all p < 0.05)
Functional Studies
HI led to impaired NB performance both in motor (CRT: -1.3 ± 
4.8 vs 1.5 ± 4.7% for SHM and HV, respectively, p < 0.05) and 
cognitive tests (NOR: 66.0 ± 4.0 vs. 46.5 ± 6.2% for SHM and 
HV, respectively, p < 0.05). CBD restored NB performance 
(CRT: -0.72 ± 5.3%, p < 0.05 vs. HV; NOR: 61.6 ± 5.2%; both p < 
0.05 vs. HV and NS vs. SHM).
A significant relationship was found 1 month after HI between 
MBP signal intensity in EC and the severity of hemiparesis, as 
assessed by CRT (R = 0.39, t = 2.6, p < 0.05) (Figure 5A), and between 
MBP signal intensity in CX and the severity of memory impairment, 
as assessed by NOR (R = 0.44, t = 2.6, p < 0.05) (Figure 5B).
Biochemical Studies
In Western Blot studies (Figure 6C-D) BDNF in its precursor form 
(proBDNF) was increased one week after the HI insult (Figure 6A). 
By contrast, no differences were observed between HV and SHAM 
when comparing the expression of its mature form (mBDNF) 
(Figure 6A). GDNF protein expression was not affected by HI seven 
days after HI (Figure 6B). CBD administration after HI had no 
effect on BDNF or GDNF protein expression so that levels in HC 
were similar to HV (Figures 6A−C).
DISCUSSION
Results from the present work have a double relevance. First, we 
hereby confirmed that acute HI insult led to the impairment of 
myelination in rat brains at a developmental stage comparable 
to that of term human infants. This is noteworthy since most 
studies on myelination impairment have focused on WM 
injury in models of very preterm or late preterm newborns 
(Back et  al., 2002a; Back et al., 2002b; Segovia et al., 2008; 
Back 2014; Back and Rosenberg 2014). In addition, we present 
for the first time a relationship between mOL damage and 
long-term functional impairment, suggesting a role for acute 
HI-induced hypomyelination on long-lasting sequelae after 
FIGURE 3 | Quantification of mature oligodendrocyte population and myelin staining in cerebral cortex. Representative microphotographs and graphical 
representation of immunohistochemical studies performed in the parieto-occipital cortex 30 days after a hypoxic-ischemic (HI) insult induced in P7–10 Wistar rats 
then receiving vehicle (HV) or cannabidiol (HC), or a similar period in control rats (SHM). (A) GST-π (mature oligodendrocyte) and (B) myelin basic protein (MBP) 
staining. Bars represent mean ± SEM. Scale bar: 50 μm. *p < 0.05 vs SHM; #p < 0.05 vs HV), by ANOVA.
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acute brain HI insult in newborns. Second, we demonstrated 
that CBD has beneficial effects in neonatal brain including OL 
protection, which complements the previously demonstrated 
protective effects of CBD on neurons and astrocytes (Schiavon 
et al., 2014; Lafuente et al., 2011; Ceprián et al., 2017). 
Beneficial effects of CBD on myelination, in addition, would 
open exciting perspectives regarding a possible role for CBD 
in different pediatric conditions related with myelin damage.
HI insult differentially affected OL in WM and CX. One month 
after the HI insult, the density of mOL cells in CX was reduced in 
FIGURE 5 | Relationship between immunohistochemical and neurobehavioral studies. Linear correlation between MBP staining intensity and different 
neurobehavioral test performed 30 days after a hypoxic-ischemic insult induced in P7–10 Wistar rats or a similar period in control rats. (A) Correlation between 
hemiparesis as assessed by the cylinder rearing test (CRT) and MBP intensity in White Matter (corpus callosum, CC); Spearman’s correlation: R = 0.396, t = 2.58, 
p = 0.013. (B) Correlation between memory impairment as assessed by novel object recognition test (NOR) and MBP intensity in cortex; Spearman’s correlation: 
R = 0.443, t = 2.57, p = 0.015).
FIGURE 4 | Myelin study in cerebral cortex by electron microscopy Electron microscopy studies performed in the parieto-occipital cortex 30 days after a hypoxic-
ischemic (HI) insult induced in P7–10 Wistar rats then receiving vehicle (HV) or cannabidiol (HC), or a similar period in control rats (SHM). (A) Number of axons 
(B) myelin sheath thickness (C) Axon perimeter (D) g-ratio (E) Dots and trend lines representing the relationship between axon size and g-ratio values 
(F) Representative micrographs. Bars represent mean ± SEM. Scale bar: 10 µm. *p < 0.05 vs SHM; #p < 0.05 vs HV), by ANOVA.
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HI compared to control rats. The reduction in the number of mOL 
resulted in reduced myelin production as reflected by the low MBP 
immunostaining signal found in CX in HI as compared to SHM rats. 
By contrast, in WM the density of mOL was similar in HI and SHM 
rats. Accordingly, quantitative myelin production was preserved, as 
reflected by the similar MBP immunostaining signal found in WM 
in HI and SHM rats. Such differences between WM and CX could 
be explained by the different maturational stage of OL in WM and 
CX at term (Segovia et al., 2008; Buser et al., 2010; Tomassy and 
Fossati, 2014). Maturation from preOL to immature OL (iOL) in 
WM starts by P2–P3 (Back et al., 2002a; Back et al., 2002b), whereas 
in CX preOL maturation happens by P7–P10 (Segovia et al., 2008; 
Tomassy and Fossati, 2014). Thus, when the HI insult was induced 
in our experiments (at P7–10) most of the maturational process 
from preOL to mOL was already accomplished in WM. Since mOL 
are far more resistant to the HI insult than preOL, the HI insult 
did not result in a decreased number of mOL, in agreement with 
previous reports (Fragoso et al., 2004; Alix 2006; Back et al., 2007; 
Volpe, 2011; Back and Rosenberg, 2014). In CX, by contrast, the 
HI insult occurred precisely when the maturational process from 
preOL to iOL is taken place. Due to the particular sensitivity of late 
preOL to HI insults, this likely resulted in impaired maturation 
form preOL to iOL, leading to a reduced number of mOL in CX, as 
reported (Back et al., 2002a; Xiong et al., 2013).
We further investigated the effects of acute HI on myelin 
production by studying axons and myelin sheath using EM. In 
agreement with our findings in IHC studies, in CX there was a 
remarkable reduction of myelinated axon number as well as a 
reduction of axonal myelin sheath thickness, as shown by a greater 
g-ratio in HI than in SHM rats. Interestingly, similar results were 
obtained in WM, including a thinner myelin sheath in axons in HI 
than in SHM rats as reflected by the greater g-ratio. Such a reduction of 
myelin sheath thickness was subtle enough to not significantly reduce 
gross myelin production as quantified by MBP immunostaining, but 
suggests that, even though the number of mOL was not reduced in 
WM by HI, myelination was impaired after HI. Myelination is still 
in progress after birth with OL extending their processes to axons 
and developing the myelin sheath (Back et al., 2002b). This process is 
very sensitive to excitotoxicity and inflammation (Miron et al., 2013; 
Jantzie et al., 2015), which are still present in the immature brain 
several days after the HI insult (Hedtjarn et al., 2002; Winerdal et al., 
2012). In WM, the more sensitive axons to those insults are those 
preparing to myelinate, which are those with a smaller diameter 
(Alix et  al., 2012). HI-induced damage of those axons interferes 
with the appropriate cross-talk between axon and OL resulting in 
impaired myelination even in absence of gross reduction of OL 
cell density (Alix et al., 2012). This in agreement with the results of 
our study, in which HV animals showed in WM a trend to present 
higher g-ratios in the smaller axons as compared to SHM despite a 
similar density of OL cells. By contrast, in CX impaired myelination 
resulted from the direct damage of mOL, as showed by the reduction 
of mOL cell density in HV with no differences in the axon size-g-
ratio relationship.
Another remarkable finding of our work is that we present, for 
the first time, a direct relationship between myelination impairment 
and functional sequelae after an acute HI insult in rats with a 
developmental stage comparable to term infants. Conceivably, 
myelin density at WM correlated with hemiparesis severity, since 
the WM constituted the path for axons coming from cortex motor 
neurons to the medulla (Brus-Ramer et al., 2009). Interestingly, 
myelin density at parietal CX correlated with working memory 
impairment, as assessed by the NOR test. NOR test is impaired in 
rats suffering from HI insult at the neonatal period, this finding 
being attributed to hippocampus damage (Pazos et  al., 2012). 
However, parietal and other different cortical areas are determinant 
in memory circuitry too by influencing perirrhinal and entorrhinal 
cortex actions on hippocampus (Dere et al., 2007).
It is noteworthy that administration of CBD prevented the 
HI-induced disturbance of myelination. Thus, HI rats receiving 
CBD did not show the quantitative reduction of myelin production 
observed in CX form HV rats 1 month after HI. More importantly, 
CBD administration after the HI insult at P7–10 resulted in a normal 
FIGURE 6 | Determination of neuroproliferative factor expression. Western blot studies performed in the parieto-occipital cortex seven days after a hypoxic-ischemic 
(HI) insult induced in P7–10 Wistar rats then receiving vehicle (HV) or cannabidiol (HC), or a similar period in control rats (SHM). (A) Quantitative determination 
of the precursor (proBDNF) and mature (mBDNF) isoforms of brain-derived neurotrophic factor (BDNF) expression (B) Quantitative determination of glia-derived 
neurotrophic factor (GDNF) expression. Bars represent mean ± SEM. (C) Representative Western blot of proBDNF and mBDNF, GDNF. (D) Representative stain-free 
total protein image. *p < 0.05 vs SHM, by ANOVA.
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number of myelinated axons and normal axonal myelin sheath 
thickness at P37 in both WM and CX. In WM, CBD treatment 
did not modify mOL cell density but resulted in a similar pattern 
and relationship between axon size and g-ratio than that of SHM, 
suggesting that in WM, rather than preserving the density of mOL 
cells CBD was protecting the axons preparing to myelinate thus 
preserving an appropriate myelination. In CX, CBD treatment did 
restore mOL cell density, suggesting that in this area protection of 
OL cell maturation was one of the effects of CBD treatment. There 
are no reports on the effect of CBD on myelination after acute brain 
insults, although there is evidence for CBD reducing demyelination 
and axonal loss in spinal cord in inflammation-mediated models 
of multiple sclerosis in mice (Giacoppo et  al., 2015; Feliú et al., 
2015; Rahimi et al., 2015). In vitro, CBD reduces preOL apoptosis 
by reducing oxidative stress because of its antioxidant properties 
and reducing inflammation damage by modulating endoplasmic 
reticulum stress (Mecha et al., 2012). We have previously reported in 
this model that post-HI administration of CBD results in a reduction 
of both glutamate and TNFα concentration seven days after the HI 
insult (Pazos et al., 2012). Furthermore, we have observed that CBD 
administration modulated oxidative stress over the days following 
HI, so that at P14 protein nitrosylation in HC rats was similar to 
control and lower than in HV rat (Téllez et al., unpublished data). 
OL are particularly sensitivity to oxidative stress because of their 
undeveloped antioxidant system and high iron content (Fragoso 
et al., 2004; Volpe, 2011). OL cell body shows an increased AMPA 
receptor expression (Volpe, 2009), whereas OL processes extended 
to axons to create the myelin sheath highly express NMDA receptors 
(Follett et al., 2004; Salter and Fern, 2005). Overactivation of those 
receptors because of a massive release of glutamate, as in HI, results 
in OL cell death and processes retraction and then to myelination 
failure (Follett et al., 2004; Salter and Fern, 2005; Volpe, 2009), in 
accordance with our observances in the EM studies. It has been 
reported that TNFα has direct pro-apoptotic effects on preOL 
(Deng et al., 2008; Kim et al., 2011; Kaur et al., 2013). There were 
no differences in the expression of pro-proliferative factors as 
BDNF or GDNF in HI rats treated with vehicle or CBD, suggesting 
that CBD effects on myelination were not due to a direct pro-
proliferative effect. Besides, that CBD was protecting axons or OL 
cells depending on the area suggests that CBD neuroprotective 
effects were not specific for a particular cell. Instead, it is likely that 
CBD’s effects on myelination after HI relied on CBD’s modulation 
of excitotoxicity, inflammation, and oxidative stress in the days 
following HI, factors which immature brain OL and premyelinating 
axons are particularly sensitive to (Alix, 2006; Deng et al., 2008; Kim 
et al., 2011; Volpe, 2011; Alix et  al., 2012; Kaur et al., 2013; Back and 
Rosenberg, 2014; Zhao et al., 2016). However, more experiments are 
needed to fully determine the mechanisms of CBD’s myelination 
protection described in the present work.
The current standard of care for HI newborns, hypothermia, has 
demonstrated similar results to CBD in a similar model. In Sprague-
Dawley rats undergoing an HI insult at PND7, hypothermia 
prevents preOL accumulation in WM 40 days after the HI insult by 
promoting maturation of preOL into mOL, resulting in increased 
MBP signal and increased number of myelinated axons (Xiong 
et al., 2013). Erythropoietin, another experimental neuroprotective 
substance administered to P7 Sprague-Dawley rats after an HI 
insult prevents HI-induced decrease of mOL number and MBP 
signal in WM and CX as assessed 14 days after the HI insult (Iwai 
et al., 2010). However, erythropoietin administered to P9 mice after 
a HI insult did not prevent HI-induced decrease of MBP signal in 
the long term (Fan et al., 2011). There are no reports on the effects of 
other promising experimental neuroprotectants, such as melatonin, 
in a model similar to ours. In a model of focal ischemic damage in 
P7 Wistar rats, melatonin prevents the subsequent decrease of mOL 
number and MBP signal, but that effect was assessed just 48 h after 
the insult (Villapol et al., 2011).
In conclusion, our study confirms that a HI insult in rats at 
a brain developmental stage equivalent to term infants leads to 
long-lasting myelination disturbance which is directly related 
to long-term functional disturbances. The administration 
of CBD single dose after the neonatal HI insult protects the 
maturational process of OL cells, as well as the mOL function and 
relationship with axons, thus, preserving normal myelination and 
restoring neurobehavioral function. Those results open exciting 
perspectives regarding a possible role for CBD in NHIE and other 
demyelinating pediatric conditions.
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